Suppr超能文献

基于多重离子交换膜的 microRNA(MIX·miR)检测平台,用于快速诊断心肌梗死。

A multiplexed ion-exchange membrane-based miRNA (MIX·miR) detection platform for rapid diagnosis of myocardial infarction.

机构信息

Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN 46556, USA.

Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN 46556, USA.

出版信息

Lab Chip. 2021 Oct 12;21(20):3876-3887. doi: 10.1039/d1lc00685a.

Abstract

Micro RNAs (miRNAs) have shown great potential as rapid and discriminating biomarkers for acute myocardial infarction (AMI) diagnosis. We have developed a multiplexed ion-exchange membrane-based miRNA (MIX·miR) preconcentration/sensing amplification-free platform for quantifying in parallel a panel of miRNAs, including miR-1, miR-208b, and miR-499, from the same plasma samples from: 1) reference subjects with no evident coronary artery disease (NCAD); 2) subjects with stable coronary artery disease (CAD); and 3) subjects experiencing ST-elevation myocardial infarction (STEMI) prior to (STEMI-pre) and following (STEMI-PCI) percutaneous coronary intervention. The picomolar limit of detection from raw plasma and 3-decade dynamic range of MIX·miR permits detection of the miRNA panel in untreated samples from disease patients and its precise standard curve, provided by large 0.1 to 1 V signals and eliminates individual sensor calibration. The use of molecular concentration feature reduces the assay time to less than 30 minutes and increases the detection sensitivity by bringing all targets close to the sensors. miR-1 was low for NCAD patients but more than one order of magnitude above the normal value for all samples from three categories (CAD, STEMI-pre, and STEMI-PCI) of patients with CAD. In fact, miR-1 expression levels of stable CAD, STEMI-pre and STEMI-PCI are each more than 10-fold higher than the previous class, in that order, well above the 95% confidence level of MIX·miR. Its overexpression estimate is significantly higher than the PCR benchmark. This suggests that, in contrast to protein biomarkers of myocardial injury, miR-1 appears to differentiate ischemia from both reperfusion injury and non-AMI CAD patients. The battery-operated MIX·miR can be a portable and low-cost AMI diagnostic device, particularly useful in settings where cardiac catheterization is not readily available to determine the status of coronary reperfusion.

摘要

微小 RNA(miRNA)作为急性心肌梗死(AMI)诊断的快速、有区别的生物标志物,具有很大的潜力。我们开发了一种基于多重离子交换膜的 miRNA(MIX·miR)预浓缩/无感应放大平台,用于同时定量分析来自同一血浆样本的一组 miRNA,包括 miR-1、miR-208b 和 miR-499:1)无明显冠状动脉疾病(NCAD)的参考对象;2)稳定型冠状动脉疾病(CAD)患者;3)经皮冠状动脉介入治疗(PCI)前(STEMI-pre)和经皮冠状动脉介入治疗(STEMI-PCI)后(STEMI-PCI)的 ST 段抬高型心肌梗死(STEMI)患者。从原始血浆中检测到的皮摩尔级检测限和 3 个数量级的 MIX·miR 动态范围允许在未经处理的疾病患者样本中检测 miRNA 谱,其精确的标准曲线由大 0.1 至 1 V 的信号提供,并消除了单个传感器校准。分子浓度特征的使用将检测时间缩短至 30 分钟以内,并通过将所有目标接近传感器来提高检测灵敏度。NCAD 患者的 miR-1 水平较低,但与 CAD 患者三个类别的所有样本(CAD、STEMI-pre 和 STEMI-PCI)的正常水平相比,超过一个数量级。事实上,稳定型 CAD、STEMI-pre 和 STEMI-PCI 的 miR-1 表达水平均比前一类高 10 倍以上,按此顺序,远高于 MIX·miR 的 95%置信水平。其过表达估计明显高于 PCR 基准。这表明,与心肌损伤的蛋白质生物标志物相比,miR-1 似乎可以区分缺血与再灌注损伤和非 AMI CAD 患者。基于电池的 MIX·miR 可以成为一种便携式、低成本的 AMI 诊断设备,特别是在心脏导管术不易获得以确定冠状动脉再灌注状态的情况下,非常有用。

相似文献

引用本文的文献

5
3D bioprinted aged human post-infarct myocardium tissue model.3D生物打印的老年人心肌梗死后组织模型
Health Sci Rep. 2024 Apr 22;7(4):e1945. doi: 10.1002/hsr2.1945. eCollection 2024 Apr.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验